Literature DB >> 17955473

Proteomic analysis of p16ink4a-binding proteins.

Elielson Souza-Rodrígues1, Josep M Estanyol, Erica Friedrich-Heineken, Eva Olmedo, Jorge Vera, Nuria Canela, Sonia Brun, Neus Agell, Ulrich Hübscher, Oriol Bachs, Montserrat Jaumot.   

Abstract

The p16(ink4a) tumor suppressor protein plays a critical role in cell cycle control, tumorogenesis and senescence. The best known activity for p16(ink4a) is the inhibition of the activity of CDK4 and CDK6 kinases, both playing a key role in cell cycle progression. With the aim to study new p16(ink4a) functions we used affinity chromatography and MS techniques to identify new p16(ink4a)-interacting proteins. We generated p16(ink4a) columns by coupling the protein to activated Sepharose 4B. The proteins from MOLT-4 cell line that bind to p16(ink4a) affinity columns were resolved by SDS-PAGE and identified by MS using a MALDI-TOF. Thirty-one p16(ink4a) -interacting proteins were identified and grouped in functional clusters. The identification of two of them, proliferating cell nuclear antigen (PCNA) and minichromosome maintenance protein 6 (MCM6), was confirmed by Western blotting and their in vivo interactions with p16(ink4a) were demonstrated by immunoprecipitation and immunofluorescence studies. Results also revealed that p16(ink4a) interacts directly with the DNA polymerase delta accessory protein PCNA and thereby inhibits the polymerase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955473     DOI: 10.1002/pmic.200700133

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  15 in total

1.  Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE.

Authors:  Stephanie M Pütz; Fotini Vogiatzi; Thorsten Stiewe; Albert Sickmann
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

2.  Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry.

Authors:  Fang Wu; Peng Wang; Leah C Young; Raymond Lai; Liang Li
Journal:  Am J Pathol       Date:  2009-01-08       Impact factor: 4.307

3.  Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma.

Authors:  Yue Liu; Shang-Tao Wan; Ping Zhang; Wen-Xin Zhang; Jian-Ling Zheng; Jian-Xian Lin; Yong-Ping Li
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

4.  The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.

Authors:  Huda H Al-Khalaf; Peer Mohideen; Shreeram C Nallar; Dhananjaya V Kalvakolanu; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2013-10-27       Impact factor: 5.157

5.  p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.

Authors:  Mysoon M Al-Ansari; Siti-Fauziah Hendrayani; Asma Tulbah; Taher Al-Tweigeri; Afaf I Shehata; Abdelilah Aboussekhra
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

6.  Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation.

Authors:  Payal Agarwal; Patricia DeInnocentes; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-30       Impact factor: 2.416

7.  Identification of nitration sites by peroxynitrite on p16 protein.

Authors:  Yunjing Luo; Jingjing Li; Na Zhang; Yunhai Wang; Rugang Zhong
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

8.  p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.

Authors:  M M Al-Ansari; S F Hendrayani; A I Shehata; A Aboussekhra
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

9.  Data integration workflow for search of disease driving genes and genetic variants.

Authors:  Sirkku Karinen; Tuomas Heikkinen; Heli Nevanlinna; Sampsa Hautaniemi
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

10.  Optimization of immunolocalization of cell cycle proteins in human corneal endothelial cells.

Authors:  Zhiguo He; Nelly Campolmi; Binh-Minh Ha Thi; Jean-Marc Dumollard; Michel Peoc'h; Olivier Garraud; Simone Piselli; Philippe Gain; Gilles Thuret
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.